Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue 3/2020

Content (12 Articles)

Acute Myeloid Leukemia Original Article

Towards better combination regimens of cytarabine and FLT3 inhibitors in acute myeloid leukemia

Mohamed Elmeliegy, Jason Den Haese, Chetasi Talati, Meir Wetzler, William J. Jusko

Open Access Pharmacokinetics Original Article

Effect of high-fat diet on the pharmacokinetics and safety of flumatinib in healthy Chinese subjects

Yun Kuang, Hui-ling Song, Guo-ping Yang, Qi Pei, Xiao-yan Yang, Ling Ye, Shuang Yang, Shu-ting Wu, Can Guo, Qing-nan He, Jie Huang

Open Access Non-Hodgkin Lymphoma Original Article

Asian race and origin have no clinically meaningful effects on polatuzumab vedotin pharmacokinetics in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

Rong Shi, Tong Lu, Grace Ku, Hao Ding, Tomohisa Saito, Leonid Gibiansky, Priya Agarwal, Xiaobin Li, Jin Yan Jin, Sandhya Girish, Dale Miles, Chunze Li, Dan Lu

Open Access Glucocorticoid Original Article

miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway

Marianna Lucafò, Daria Sicari, Andrea Chicco, Debora Curci, Arianna Bellazzo, Alessia Di Silvestre, Chiara Pegolo, Robert Autry, Erika Cecchin, Sara De Iudicibus, Licio Collavin, William Evans, Giuliana Decorti, Gabriele Stocco

Glioblastoma Original Article

Temozolomide desensitization followed by metronomic dosing in patients with hypersensitivity

Bryan J. Neth, Michael W. Ruff, Joon H. Uhm, Derek R. Johnson, Rohit D. Divekar, Daniel E. Maddox

Neuropathic Pain Original Article

Aripiprazole prevents from development of vincristine-induced neuropathic nociception by limiting neural NOS overexpression and NF-kB hyperactivation

Mina Khalilzadeh, Fereshteh Hassanzadeh, Helia Aghamiri, Ahmad Reza Dehpour, Hamed Shafaroodi

Ultrasound Original Article

Novel biomimetic dual-mode nanodroplets as ultrasound contrast agents with potential ability of precise detection and photothermal ablation of tumors

Yuan Liang, Hengli Yang, Qiaoying Li, Ping Zhao, Han Li, Yuxin Zhang, Wenbin Cai, Xiaoju Ma, Yunyou Duan

Cytokines Original Article

Aloin alleviates doxorubicin-induced cardiotoxicity in rats by abrogating oxidative stress and pro-inflammatory cytokines

Lalit Birari, Shivani Wagh, Kalpesh R. Patil, Umesh B. Mahajan, Banappa Unger, Sateesh Belemkar, Sameer N. Goyal, Shreesh Ojha, Chandragouda R. Patil

Neutropenia Original Article

Neutropenia is an indicator of outcomes in metastatic colorectal cancer patients treated with FTD/TPI plus bevacizumab: a retrospective study

Yohei Nose, Yoshinori Kagawa, Taishi Hata, Ryota Mori, Kenji Kawai, Atsushi Naito, Takuya Sakamoto, Kohei Murakami, Yoshiteru Katsura, Yoshiaki Ohmura, Toru Masuzawa, Atsushi Takeno, Yutaka Takeda, Takeshi Kato, Kohei Murata

Open Access Original Article

Evaluation of patient-reported severity of hand–foot syndrome under capecitabine using a Markov modeling approach

Eduard Schmulenson, Linda Krolop, Sven Simons, Susanne Ringsdorf, Yon-Dschun Ko, Ulrich Jaehde

Open Access Pharmacokinetics Short Communication

Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis

A. Laura Nijstad, Natasha K. A. van Eijkelenburg, Kathelijne C. J. M. Kraal, Marieke J. M. Meijs, Clara T. M. M. de Kanter, Marc R. Lilien, Alwin D. R. Huitema

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine